Next Article in Journal
Cuban Brown Propolis Interferes in the Crosstalk between Colorectal Cancer Cells and M2 Macrophages
Next Article in Special Issue
Effect of Food with Low Enrichment of N-3 Fatty Acids in a Two-Month Diet on the Fatty Acid Content in the Plasma and Erythrocytes and on Cardiovascular Risk Markers in Healthy Young Men
Previous Article in Journal
Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study
Previous Article in Special Issue
Supplementation of Re-Esterified Docosahexaenoic and Eicosapentaenoic Acids Reduce Inflammatory and Muscle Damage Markers after Exercise in Endurance Athletes: A Randomized, Controlled Crossover Trial
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 12
Issue 7
10.3390/nu12072045
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003–2014

by
Caleb Cave
1,
Nicholas Hein
2,
Lynette M. Smith
2,
Ann Anderson-Berry
1,
Chesney K. Richter
3,
Karl Stessy Bisselou
2,
Adams Kusi Appiah
2,
Penny Kris-Etherton
4,
Ann C. Skulas-Ray
3,
Maranda Thompson
1,
Tara M. Nordgren
5,*,
Corrine Hanson
6 and
Melissa Thoene
1,*
1
Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE 68198, USA
2
College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA
3
Department of Nutritional Sciences, University of Arizona, Tucson, AZ 85721, USA
4
Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA 16802, USA
5
Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA 92521, USA
6
College of Allied Health Professions, University of Nebraska Medical Center, Omaha, NE 68198, USA
*
Authors to whom correspondence should be addressed.
Nutrients 2020, 12(7), 2045; https://doi.org/10.3390/nu12072045
Submission received: 7 May 2020 / Revised: 24 June 2020 / Accepted: 26 June 2020 / Published: 9 July 2020
(This article belongs to the Special Issue Omega-3 Polyunsaturated Fatty Acids and Human Health)
Browse Figures
Review Reports Versions Notes

Abstract

:
Although there are many recognized health benefits for the consumption of omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA), intake in the United States remains below recommended amounts. This analysis was designed to provide an updated assessment of fish and n-3 LCPUFA intake (eicosapentaenoic (EPA), docosahexaenoic acid (DHA), and EPA+DHA) in the United States adult population, based on education, income, and race/ethnicity, using data from the 2003–2014 National Health and Nutrition Examination Survey (NHANES) (n = 44,585). Over this survey period, participants with less education and lower income had significantly lower n-3 LCPUFA intakes and fish intakes (p < 0.001 for all between group comparisons). N-3 LCPUFA intake differed significantly according to ethnicity (p < 0.001), with the highest intake of n-3 LCPUFA and fish in individuals in the “Other” category (including Asian Americans). Supplement use increased EPA + DHA intake, but only 7.4% of individuals consistently took supplements. Overall, n-3 LCPUFA intake in this study population was low, but our findings indicate that individuals with lower educational attainment and income are at even higher risk of lower n-3 LCPUFA and fish intake.

1. Introduction

Omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA), particularly eicosapentaenoic (EPA) and docosahexaenoic acid (DHA), can offer many health benefits when regularly consumed in sufficient quantities. Health benefits of n-3 LCPUFA include reduction of preterm birth, decreased risk for low birth weight in infants, improved visual acuity in infants, facilitation of early childhood neurodevelopment, inflammation modulation such as with chronic disease or cancer-related complications, risk reduction of cardiovascular disease (CVD), prevention of dementia and cognitive decline, and a decreased risk for developing age-related macular degeneration [1,2,3,4,5,6,7,8,9,10,11,12,13].
There are currently no Recommended Dietary Allowances or Dietary Reference Intakes set for EPA or DHA. Other government and public health agencies have offered recommendations, but these vary widely and are based primarily on age or gender [14,15,16]. Although symptomatic polyunsaturated fatty acid deficiency, which presents with scaly skin and dermatitis, is very rare in the United States (US), the Western diet typically includes lower amounts of n-3 LCPUFA than those recommended for age and gender groups by the National Institutes of Health and the World Health Organization [14,17,18,19,20] (Table 1).
EPA and DHA are the most common forms of n-3 LCPUFA in the human diet and are primarily found in fatty, cold-water fish and other seafood. Alpha-linolenic acid (ALA), the precursor to EPA and DHA, is an essential n-3 fatty acid that cannot be synthesized in the human body [21] and must be obtained from the diet—primarily from plant-based sources such as flaxseed oil, canola oil, chia seeds, and walnuts [22]. Conversion of ALA to EPA and DHA in adults is extremely low (<10%), and may also differ by sex [23,24]. Therefore, fatty fish is considered the primary source of n-3 LCPUFA in the human diet [22]. Supplementation with fish oil, krill oil, or products derived from algal sources can also provide substantial amounts of n-3 LCPUFA [20].
Differences in n-3 LCPUFA intake exist among subgroups of the US population. For example, our recent analysis of NHANES (National Health and Nutrition Examination Survey) 2003–2014 data revealed differences in n-3 LCPUFA intake based on age, gender, and pregnancy status [25]. Overall, n-3 LCPUFA intake was significantly lower in women compared to men, younger participants (regardless of gender), and pregnant women (compared to their non-pregnant counterparts) [25]. Other analyses of NHANES data from 2003 to 2014 have further demonstrated lower n-3 LCPUFA intakes in pregnant women or women of child-bearing age and younger participants (compared to their male and older counterparts) [26,27]. These recent findings strongly suggest that n-3 LCPUFA intake is influenced by factors such as gender and pregnancy status.
Much less is known about the potential role of other demographic factors on n-3 LCPUFA intake, such as ethnicity, income, and education level. A recent analysis of NHANES 2011–2014 data suggested that n-3 LCPUFA intake varies by ethnicity in the US, with non-Hispanic Asians consuming significantly more EPA and DHA than Hispanics, non-Hispanic Whites, and non-Hispanic Blacks [28]. However, in NHANES 2005–2010, overall fish intake in the US did not differ based on race/ethnicity but was directly correlated with income and education [29]. To our knowledge, this relationship has not yet been described for intake of fish high in n-3 LCPUFA. Additionally, no similar analyses of NHANES data spanning more than a 5-year period have been conducted and additional research is needed to further evaluate the relationship between n-3 LCPUFA intake with ethnicity, income, and education.
The purpose of this study was to identify subgroups of the US population that are at greater risk for low n-3 LCPUFA intake (EPA, DHA, and EPA + DHA) by comparing differences in current intake according to education level, ethnicity, and income. Fish intake (both overall fish intake and intake of fish high in n-3 LCPUFA, EPA and DHA) and supplement use were also compared among these population subgroups.

2. Materials and Methods

Demographics and dietary interviews from six cycles of NHANES (2003–2004, 2005–2006, 2007–2008, 2009–2010, 2011–2012, and 2013–2014) were used for the analysis. Data on total nutrient intake were collected from two 24 h dietary recall interviews. Dietary supplement use was assessed over a 30-day period. EPA and DHA intake from supplements was calculated using an external list of over-the-counter supplements, as described by Thompson et al. [25]. All statistical analyses were performed in R (version 3.4.2; R Core Team, 2017; Vienna, Austria) using the SURVEY package [30,31,32]. Statistical significance was set at p < 0.05.
NHANES uses a complex survey design and represents the civilian, noninstitutionalized US population. Detailed methodology of NHANES has been described elsewhere [33]. Dietary sampling weights were used for all analyses and adjusted to account for multiple cycles. All individuals aged 1 year or older were included in the analysis, except for pregnant females. Additionally, adults (19 years or older) were excluded if their daily caloric intake was <800 or >8000 for males and <600 or >6000 for females. Caloric intake was calculated as the average caloric intake from the 1st and 2nd day of 24-h dietary recalls. If the 2nd day was missing, the average caloric intake was set to the 1st day.
Demographics of the sample are reported as frequencies for categorical variables and as means with standard error of the mean for continuous variables. Race was categorized as non-Hispanic White, non-Hispanic Black, Mexican-American, Other Hispanic, and Other. Education was categorized as <high school and <19 years old, <high school and ≥19 years old, completed high school, and completed school beyond high school. Poverty-Income Ratio (PIR) was dichotomized at the median of the sample (i.e., 2.73) and also at the federal poverty line (FPL) (i.e., 1). EPA and DHA intakes were calculated as the average of the 1st and 2nd day values from the 24-h dietary recall. As with caloric intake, if the 2nd day was missing, only the 1st day was used. EPA and DHA were further adjusted for average caloric intake. Total fish intake in the last 30 days was calculated based on the number of times a respondent reported eating each of the 31 types of fish included in the NHANES survey. The number of times a particular fish was consumed in the last 30 days was assumed to be zero if an individual responded “No” for eating that fish. Intake of fish high in n-3 LCPUFA was calculated using the above-described method, but limited to 7 fish only (tuna, mackerel, salmon, sardines, shark, swordfish, and trout), similar to previous NHANES analysis of n-3 LCPUFA intake [25]. Comparisons of EPA/DHA (milligrams/1000 kilocalorie or mg/1000 kcal) intake and fish eaten in the last 30 days by race, education, and income were made by fitting a generalized linear model and using a Rao–Scott test to determine whether all coefficients were zero. N-3 LCPUFA intakes (mg) were adjusted per 1000 kcal to control for variation in individual energy requirements based on sex, physical activity, age, and/or body size.
EPA/DHA intake (mg/1000 kcal) in supplement users and non-supplement users was compared using a t-test. Supplement users were further dichotomized as taking a supplement with or without EPA/DHA. For individuals taking a supplement containing EPA/DHA, total EPA/DHA intake was calculated using the label information provided for each over-the-counter supplement, as previously described by Thompson et al. [25]. The mean intake of EPA/DHA (mg/1000 kcal) was then compared among non-supplement users, individuals taking a supplement without EPA/DHA, and individuals taking a supplement with EPA/DHA by fitting a generalized linear model and using a Rao–Scott test to determine whether all coefficients were zero.

3. Results

3.1. Participant Characteristics

Characteristics of the participant population (n = 44,585) and average EPA, DHA, and EPA+DHA intakes are provided in Table 2, according to specified population subgroups.

3.2. EPA, DHA, and EPA+DHA Intake by Ethnicity, Education Level, and Income

EPA, DHA, and EPA+DHA intake among all ethnic groups included in the analysis are shown in Figure 1. EPA and EPA+DHA intake among ethnicities followed a specific trend: Other > Non-Hispanic Black > Other Hispanic > Non-Hispanic White > Mexican American.
Regarding educational attainment, participants with greater than high school education had significantly higher dietary intake of EPA and combined EPA+DHA than those with a high school education or lower than a high school education (p < 0.05; Figure 2). Participants who graduated from high school and those who did not finish high school and were ≥19 years old consumed significantly more EPA, DHA, and EPA+DHA than participants who did not finish high school and were <19 years old (p < 0.0001).
Daily EPA and DHA intake also differed significantly according to income, whether income was stratified according to median PIR or the Federal Poverty Line (p < 0.001; Figure 3).

3.3. Fish Intake by Ethnicity, Education Level, and Income

Significant differences in the intake of total fish and fish high in n-3 LCPUFA were found across all ethnic groups (p < 0.001). Individuals categorized in the “Other” category had the highest mean intake of both total fish and fish high in n-3 LCPUFA (9.7 servings/month and 2.7 servings/month, respectively) while Mexican Americans had the lowest intake (5.7 servings/month and 1.6 servings/month, respectively), as shown in Figure 4. Intake of total fish as was similar between Non-Hispanic Whites, Non-Hispanic Blacks (7.6 servings/month each), and Other Hispanics (7.2 servings/month). However, Non-Hispanic Blacks had lower intake of fish high in n-3 LCPUFA (1.8 servings/month) compared to but Non-Hispanic Whites (2.6 servings/month) and Other Hispanics (2.2 servings/month).
A higher level of education was also associated with a greater number of servings of total fish and fish high in n-3 LCPUFA consumed over the course of 30 days: >high school (8.9 servings/month and 3 servings/month, respectively), high school (6.9 servings/month and 2.0 servings/month), <high school and ≥19 years old (6.3 servings/month and 1.6 servings/month), and <high school and <19 years old (5.2 servings/month and 1.5 servings/month) (Figure 5).
As with EPA and DHA intake by income level, intake of both total fish and fish high in n-3 LCPUFA was higher in participants with higher incomes, whether this was defined based on median Federal Poverty Line or median PIR (Figure 6) (all p < 0.001).

3.4. EPA/DHA-Containing Supplement Use by Ethnicity, Education Level, and Income

EPA/DHA-containing supplements were used by 7.4% of all participants. EPA and DHA intake were both significantly higher in participants who reported the use of any supplement (whether it contained n-3 LCPUFA or not) compared to those who did not report any supplement use (Figure 7 and Figure 8; all p < 0.001). Participants taking supplements containing EPA/DHA had significantly higher intake of EPA and DHA per 1000 kcal (163.9 mg and 144.5 mg, respectively) when compared to those taking supplements without EPA/DHA (16.6 mg and 33.1 mg, respectively) and those not taking any supplements at all (14.9 mg and 29.7 mg, respectively) (all p < 0.001). EPA/DHA supplement use increased with both education and income level (Table 3), matching the trend found for EPA+DHA and fish intake. As for EPA/DHA supplement use by ethnicity, supplement use was highest in Non-Hispanic Whites (6.0%) and below 0.5% of the population for other subgroups.

4. Discussion

Our analysis of NHANES 2003–2014 demonstrates that there are significant differences in n-3 LCPUFA intake among the US population based on ethnicity, education level, and income. Overall, EPA/DHA intake, as well as supplement use and the consumption of fish high in n-3 LCPUFA, increased in conjunction with education and income. This consistent pattern suggests that socioeconomically disadvantaged populations within the US are at heightened risk for lower n-3 LCPUFA intake, which may further contribute to health disparities.
Previous analyses have indicated similar disparities in n-3 LCPUFA intake. In an analysis of NHANES 2011–2014 data, overall supplement use by adults was higher in participants who were well above the poverty level, were food-secure, and did not participate in SNAP (Supplemental Nutritional Assistance Program)—regardless of age, gender, and ethnicity [34]. A similar trend has also been illustrated in Australia, where an analysis of the national Australian Health Survey revealed that unemployed citizens with less educational attainment tended to consume less fish overall, with a higher proportion of fish that are lower in n-3 LCPUFA content, when compared to higher-educated, higher-earning counterparts [35]. This pattern may be attributed to many factors, including lack of access to information concerning proper nutrition, as well as an overall lack of resources. This could have important implications for future generations as adequate n-3 LCPUFA intake is essential for promoting early neurodevelopment [6,7,36,37]. Studies have also suggested improved memory and attention among children and adolescents with higher prenatal or current intake of n-3 LCPUFA [38,39,40]. A causal relationship between n-3 LCPUFA intake and education or income cannot be derived from our analysis, but these results raise the question of how socioeconomic disadvantage influences early-life n-3 LCPUFA intake and if this leads to additional health and developmental consequences with long-term implications.
Globally, the highest blood concentrations of n-3 LCPUFA have been found in Japan and other Asian countries, while the lowest levels are in North America, Central and South America, and most African and European countries [41]. Similarly, differences in dietary intake of n-3 LCPUFA varied between ethnic groups in our analysis. For example, EPA/DHA intake and intake of fish high in n-3 LCPUFA were consistently highest in participants categorized as “Other” for ethnicity, which includes Asian-Americans. This is consistent with analyses of NHANES 2011–2014 that found non-Hispanic Asians consumed 2× more DHA and 3 × more EPA than other ethnic groups, with oily fish rich in n-3 LCPUFA being the highest contributor to EPA and DHA intake [28]. Interestingly, non-Hispanic Blacks had the second highest intake of EPA and DHA in our analysis, but the second lowest intake of fish high in n-3 LCPUFA, indicating that this subpopulation’s primary dietary sources of n-3 LCPUFA are not the standard sources highest in EPA and DHA (i.e., fatty, cold-water fish such as salmon, mackerel, tuna, and sardines). Further research is needed to identify the primary sources of n-3 LCPUFA intake in this population, but it is possible that this is due to the consumption of foods fortified with n-3 LCPUFA.
With regard to supplement use and n-3 LCPUFA intake, reported use of EPA/DHA-containing supplements was low in all ethnicity categories. Notably, despite having the highest use of EPA/DHA supplements, non-Hispanic Whites still had the 2nd lowest overall n-3 LCPUFA intake of any ethnic group. Thus, although EPA/DHA supplements are a potentially viable alternative to dietary sources of n-3 LCPUFA, the small number of individuals using these supplements does not significantly increase the overall n-3 LCPUFA intake of the subpopulation. In addition to supplements, fortified foods, and other alternatives may be beneficial and deserve further consideration as a means of increasing n-3 LCPUFA intake in the US.
Compared to EPA + DHA intakes recommended by the World Health Organization (200–250 mg/day for adults) and the National Institutes of Health (270 mg/day), average intake in this US population remained far below recommended amounts at an average daily mean of approximately 100 mg [14,18]. Oily fish are the primary dietary source of n-3 LCPUFA, but very few demographic groups in our analysis met the American Heart Association’s suggested intake of 2 servings/week of fish for adults or 8 ounces/week of oily fish per the 2010 Dietary Guidelines for Americans (provides approximately 250 mg/day EPA + DHA) [42]. Additionally, although n-3 LCPUFA supplements are commonly available and can significantly augment overall EPA + DHA intake, our findings and previous research shows that only a small proportion of the population routinely uses these supplements [27]. Education and intervention approaches to increase n-3 LCPUFA intake should include a variety of strategies, including increased consumption of dietary n-3 LCPUFA sources, consistent daily use for those who choose to use EPA/DHA supplements, as well as n-3 LCPUFA fortified foods and other potential alternatives.

Strengths and Limitations

This study analyzed a large, representative sample of the US population, using a 24 h dietary recall method that is considered sufficient for accurately measuring mean dietary intake at the population level [43]. We stratified our analysis by ethnicity, education, and income but did not consider differences by gender or age. We did not assess other factors that may influence n-3 LCPUFA intake (e.g., age, gender, pregnancy, geographic regions), but prior studies have already revealed significant differences based on several of these population traits [25,26,44]. Lastly, we did not stratify education or income level by ethnicity, which could also reveal significant disparities in n-3 LCPUFA intake. Much less is known about docosapentaenoic acid (DPA), the metabolic intermediate of EPA and DHA, but existing evidence indicates that DPA may also contribute to the health benefits attributed to EPA and DHA [45,46,47]. Although we did not assess differences in dietary intake DPA alongside EPA and DHA in this analysis, we previously reported differences in DPA intake according to age, gender, and race/ethnicity in this NHANES 2003–2014 cohort [27]. It should also be noted that 24 h dietary recalls may not accurately reflect an individual’s habitual dietary pattern, and a recent study identified discrepancies in the NHANES dataset regarding energy intake values [48]. To reduce the potential effect of this, we limited our study to participants who reported plausible caloric intake ranges and excluded adult men with caloric intake of <800 kcal or >8000 kcal per day and adult women with caloric intake of <600 kcal or >6000 kcal per day. Furthermore, we also included an assessment of fish intake over a 30-day period that corroborated and expanded upon our overall results for EPA and DHA intake from 24 h dietary recalls. However, assessing n-3 LCPUFA intake based on fish consumption also has limitations as the EPA and DHA content of a particular species of fish can differ based on its source, with some species of farmed fish having substantially lower EPA and DHA content than their wild-caught counterparts [49]. Nonetheless, our results agree with other recent investigations, providing consistent evidence for interpretation [20,28,41]. The cross-sectional nature of NHANES must also be considered in the interpretation of our results, as we cannot establish any causal relationships related to intake. Additionally, there remains a lack of standardized guidelines for sufficient n-3 LCPUFA intake and research regarding the amount of n-3 LCPUFA required to support specific physiological functions remains limited. This makes the development of evidence-based recommendations for EPA and DHA intake difficult.

5. Conclusions

In this study, we assessed differences in EPA and DHA intake in the US according to ethnicity, education, and income using 2003–2014 NHANES data. Overall, EPA+DHA intake was low, with an average daily intake of 100 mg. Low educational attainment and income were consistently associated with lower n-3 LCPUFA intake. With regard to ethnicity, average n-3 LCPUFA intake was highest in the “Other” category (including Asian-Americans). Fish intake was also below recommended amounts in all demographic subgroups, except for individuals categorized as “Other” and individuals with a higher level of education and income. Use of EPA/DHA supplements was low in all population subgroups. Consumption of n-3 LCPUFA remains low in the overall US population, with even lower n-3 LCPUFA intake being more common in socioeconomically disadvantaged subpopulations and specific ethnicities, which may indicate the potential for augmenting health disparities.

Author Contributions

Conceptualization, C.H., A.A.-B., C.K.R., P.K.E., A.C.S.-R., and T.M.N.; methodology, formal analysis, writing, review, and editing, C.C., N.H., L.M.S., A.A.-B., C.K.R., K.S.B., A.K.A., P.K.-E., A.C.S.-R., M.T. (Maranda Thompson), C.H., T.M.N., and M.T. (Melissa Thoene). All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported in part by the National Institute of Environmental Health Sciences-National Institutes of Health (R00ES025819) for author T.M.N.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Thota, R.N. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: Biochemical effects vs. clinical outcomes. Food Funct. 2018, 6, 3576–3596. [Google Scholar] [CrossRef] [PubMed]
  2. Rimm, E.B.; Appel, L.J.; Chiuve, S.E.; Djoussé, L.; Engler, M.B.; Kris-Etherton, P.M.; Mozaffarian, D.; Siscovick, D.S.; Lichtenstein, A.H.; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health. Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: A science advisory from the American heart association. Circulation 2018, 138, e35–e47. [Google Scholar] [CrossRef]
  3. Roncaglioni, M.C.; Risk and Prevention Study Collaborative Group. n-3 fatty acids in patients with multiple cardiovascular risk factors. N. Engl. J. Med. 2013, 368, 1800–1808. [Google Scholar] [PubMed] [Green Version]
  4. Zhang, Y.; Chen, J.; Qiu, J.; Li, Y.; Wang, J.; Jiao, J. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies. Am. J. Clin. Nutr. 2016, 103, 330–340. [Google Scholar] [CrossRef] [PubMed]
  5. Cederholm, T.; Salem, N., Jr.; Palmblad, J. ω-3 fatty acids in the prevention of cognitive decline in humans. Adv. Nutr. 2013, 4, 672–676. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Hibbeln, J.R.; Davis, J.M.; Steer, C.; Emmett, P.; Rogers, I.; Williams, C.; Golding, J. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study. Lancet 2007, 369, 578–585. [Google Scholar] [CrossRef]
  7. Makrides, M.; Gibson, R.A.; McPhee, A.J.; Yelland, L.; Quinlivan, J.; Ryan, P. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. JAMA 2010, 304, 1675–1683. [Google Scholar] [CrossRef] [Green Version]
  8. Christen, W.G.; Schaumberg, D.A.; Glynn, R.J.; Buring, J.E. Dietary omega-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch. Ophthalmol. 2011, 129, 921–929. [Google Scholar] [CrossRef] [Green Version]
  9. Augood, C.; Chakravarthy, U.; Young, I.; Vioque, J.; De Jong, P.T.; Bentham, G.; Rahu, M.; Seland, J.; Soubrane, G.; Tomazzoli, L.; et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am. J. Clin. Nutr. 2008, 88, 398–406. [Google Scholar] [CrossRef] [Green Version]
  10. Middleton, P.; Gomersall, J.C.; Gould, J.F.; Shepherd, E.; Olsen, S.F.; Makrides, M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst. Rev. 2018. [Google Scholar] [CrossRef]
  11. Shulkin, M. n-3 fatty acid supplementation in mothers, preterm infants, and term infants and childhood psychomotor and visual development: A systematic review and meta-analysis. J. Nutr. 2018, 148, 409–418. [Google Scholar] [CrossRef] [PubMed]
  12. Freitas, R.D.; Campos, M.M. Protective effects of omega-3 fatty acids in cancer-related complications. Nutrients 2019, 11, 945. [Google Scholar] [CrossRef] [Green Version]
  13. Rangel-Huerta, O.D.; Aguilera, C.M.; Mesa, M.D.; Gil, A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomarkers: A systematic review of randomised clinical trials. Br. J. Nutr. 2012, 107 (Suppl. 2), S159–S170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition; WHO: Geneva, Switzerland, 10–14 November 2008; Available online: http://www.who.int/nutrition/topics/FFA_interim_recommendations/en/ (accessed on 30 September 2019).
  15. Omega-3 Fatty Acids. Fact Sheet for Health Professionals. 2019. Available online: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ (accessed on 30 September 2019).
  16. Simopoulos, A.P.; Leaf, A.; Salem, N. Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot. Essent. Fat. Acids 2000, 63, 119–121. [Google Scholar] [CrossRef] [PubMed]
  17. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients); National Academy Press: Washington, DC, USA, 2005. [Google Scholar]
  18. Office of Dietary Supplements—Omega-3 Fatty Acids. Available online: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ (accessed on 29 August 2019).
  19. Ervin, R.B.; Wright, J.D.; Wang, C.Y.; Kennedy-Stephenson, J. Dietary intake of fats and fatty acids for the United States population: 1999–2000. Advanced Data 2004, 348, 1–6. [Google Scholar]
  20. Kris-Etherton, P.M.; Grieger, J.A.; Etherton, T.D. Dietary reference intakes for DHA and EPA. Prostaglandins Leukot. Essent. Fat. Acids. 2009, 81, 99–104. [Google Scholar] [CrossRef]
  21. Jones, P.J.H.; Papamandjaris, A.A. Lipids: Cellular metabolism. In Present Knowledge in Nutrition, 10th ed.; Erdman, J.W.M.I., Ed.; Wiley-Blackwell: Ames, IA, USA, 2012; pp. 132–148. [Google Scholar]
  22. Harris, W. Omega-3 fatty acids. In Encyclopedia of Dietary Supplements, 2nd ed.; Coates, P.M., Betz, J.M., Blackman, M.R., Cragg, C.M., Levine, M., Moss, J., White, J.D., Eds.; Informa Healthcare: London, UK; New York, NY, USA, 2010; pp. 577–586. [Google Scholar]
  23. Burdge, G.C.; Wooton, S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 2002, 88, 411–420. [Google Scholar] [CrossRef] [Green Version]
  24. Gerster, H. Can adults adequately convert alpha-linolenic acid (18, 3n-3) to eicosapentaenoic acid (20, 5n-3) and docosahexaenoic acid (22, 6n-3)? Int. J. Vitam. Nutr. Res. 1998, 68, 159–173. [Google Scholar]
  25. Thompson, M.; Hein, N.; Hanson, C.; Smith, L.M.; Anderson-Berry, A.; Richter, C.K.; Stessy Bisselou, K.; Kusi Appiah, A.; Kris-Etherton, P.; Skulas-Ray, A.C.; et al. Omega-3 fatty acid intake by age, gender, and pregnancy status in the United States: National health and nutrition examination survey 2003–2014. Nutrients 2019, 11, 177. [Google Scholar] [CrossRef] [Green Version]
  26. Nordgren, T.M.; Lyden, E.; Anderson-Berry, A.; Hanson, C. Omega-3 fatty acid intake of pregnant women and women of childbearing age in the United States: Potential for deficiency. Nutrients 2017, 9, 197. [Google Scholar] [CrossRef] [Green Version]
  27. Richter, C.K.; Bisselou, K.S.; Nordgren, T.M.; Smith, L.; Appiah, A.K.; Hein, N.; Anderson-Berry, A.; Kris-Etherton, P.; Hanson, C.; Skulas-Ray, A.C. N-3 Docosapentaenoic acid intake and relationship with plasma long-chain N-3 fatty acid concentrations in the United States: NHANES 2003–2014. Lipids 2019, 54, 221–230. [Google Scholar] [CrossRef] [PubMed]
  28. Julián-Serrano, S.; Dodd, K.; Angleró, I.; Emenaker, N. Ethnic Disparities in EPA and DHA Intake in US Adults: Results from the NHANES 2011–2014 (P04-107-19). Curr. Dev. Nutr. 2019, 3, 107–119. [Google Scholar] [CrossRef]
  29. Jahns, L.; Raatz, S.K.; Johnson, L.K.; Kranz, S.; Silverstein, J.T.; Picklo, M.J. Intake of seafood in the US varies by age, income, and education level but not by race-ethnicity. Nutrients 2014, 6, 6060–6075. [Google Scholar] [CrossRef] [Green Version]
  30. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria. Available online: https://www.r-project.org/ (accessed on 31 October 2019).
  31. R Package Version 3 32. Survey: Analysis of Complex Survey Samples; R Foundation for Statistical Computing: Vienna, Austria, 2017.
  32. Lumley, T. Analysis of complex survey samples. J. Stat. Softw. 2004, 9, 1–19. [Google Scholar] [CrossRef] [Green Version]
  33. National Health and Nutrition Examination Survey. Available online: https://www.cdc.gov/nchs/nhanes/index.htm (accessed on 31 October 2019).
  34. Cowan, A.E.; Jun, S.; Gahche, J.J.; Tooze, J.A.; Dwyer, J.T.; Eicher-Miller, H.A.; Bhadra, A.; Guenther, P.M.; Potischman, N.; Dodd, K.W.; et al. Dietary supplement use differs by socioeconomic and health-related characteristics among U.S.; Adults, NHANES 2011–2014. Nutrients 2018, 10, 1114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Farmery, A.K.; Hendrie, G.A.; O’Kane, G. Sociodemographic variation in consumption patterns of sustainable and nutritious seafood in Australia. Front. Nutr. 2018, 5, 118. [Google Scholar] [CrossRef]
  36. Guesnet, P.; Alessandri, J.M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)—Implications for dietary recommendations. Biochimie 2011, 93, 7–12. [Google Scholar] [CrossRef]
  37. Emmett, P.M.; Jones, L.R.; Golding, J. Pregnancy diet and associated outcomes in the Avon Longitudinal Study of Parents and Children. Nutr. Rev. 2015, 73, 154–174. [Google Scholar] [CrossRef]
  38. McNamara, R.K.; Able, J.; Jandacek, R.; Rider, T.; Tso, P.; Eliassen, J.C.; Alfieri, D.; Weber, W.; Jarvis, K.; DelBello, M.P.; et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: A placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am. J. Clin. Nutr. 2010, 91, 1060–1067. [Google Scholar] [CrossRef] [Green Version]
  39. Boucher, O. Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age. Am. J. Clin. Nutr. 2011, 93, 120. [Google Scholar] [CrossRef] [Green Version]
  40. Fuentes-Albero, M. Omega-3 long-chain polyunsaturated fatty acids intake in children with attention deficit and hyperactivity disorder. Brain Sci. 2019, 9, 120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Stark, K.D. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog. Lipid Res. 2016, 63, 132–152. [Google Scholar] [CrossRef]
  42. American Heart Association. Keep Saying Yes to Fish Twice a Week for Heart Health. 2018. Available online: http://newsroom.heart.org/news/keep-saying-yes-to-fish-twice-a-week-for-heart-health (accessed on 13 September 2019).
  43. Dangardt, F.; Osika, W.; Chen, Y.; Nilsson, U.; Gan, L.M.; Gronowitz, E.; Strandvik, B.; Friberg, P. Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents. Atherosclerosis 2010, 212, 580–585. [Google Scholar] [CrossRef] [PubMed]
  44. Sheppard, K.W.; Cheatham, C.L. Omega-6/omega-3 fatty acid intake of children and older adults in the U.S.: Dietary intake in comparison to current dietary recommendations and the Healthy Eating Index. Lipids Health Dis. 2018, 17, 43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Kaur, G. Short update on docosapentaenoic acid: A bioactive long-chain n-3 fatty acid. Curr. Opin. Clin. Nutr. Metab. Care. 2016, 19, 88–91. [Google Scholar] [CrossRef] [PubMed]
  46. Kaur, G. Docosapentaenoic acid (22, 5n-3): A review of its biological effects. Prog. Lipid Res. 2011, 50, 28–34. [Google Scholar] [CrossRef] [Green Version]
  47. Skulas-Ray, A. Red blood cell Docosapentaenoic acid (DPA n-3) is inversely associated with triglycerides and C-reactive protein (CRP) in healthy adults and dose-dependently increases following n-3 fatty acid supplementation. Nutrients 2015, 7, 6390–6404. [Google Scholar] [CrossRef] [Green Version]
  48. Murakami, K. Prevalence and characteristics of misreporting of energy intake in US adults: NHANES 2003–2012. Br. J. Nutr. 2015, 114, 1294–1303. [Google Scholar] [CrossRef] [Green Version]
  49. Sprauge, M.; Dick, J.R.; Tocher, D.R. Impact of sustainable feeds on omega-3 long-chain fatty acid levels in farmed Atlantic salmon, 2006–2015. Sci. Rep. 2016, 6, 21892. [Google Scholar] [CrossRef] [Green Version]
Nutrients 12 02045 g001 550
Figure 1. Omega-3 LCPUFA intake (mg per 1000 kcal) by race/ethnicity. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between race/ethnicity groups in post hoc pairwise comparisons (p < 0.05).
Figure 1. Omega-3 LCPUFA intake (mg per 1000 kcal) by race/ethnicity. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between race/ethnicity groups in post hoc pairwise comparisons (p < 0.05).
Nutrients 12 02045 g001
Nutrients 12 02045 g002 550
Figure 2. Omega-3 LCPUFA intake (mg per 1000 kcal) by education level. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between education groups in post hoc pairwise comparisons (p < 0.05).
Figure 2. Omega-3 LCPUFA intake (mg per 1000 kcal) by education level. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between education groups in post hoc pairwise comparisons (p < 0.05).
Nutrients 12 02045 g002
Nutrients 12 02045 g003 550
Figure 3. Omega-3 LCPUFA intake (mg per 1000 kcal) by Federal Poverty Line (A) and Poverty Income Ratio (PIR) (B). Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). p-values represent within group comparisons for each n-3 LCPUFA.
Figure 3. Omega-3 LCPUFA intake (mg per 1000 kcal) by Federal Poverty Line (A) and Poverty Income Ratio (PIR) (B). Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). p-values represent within group comparisons for each n-3 LCPUFA.
Nutrients 12 02045 g003
Nutrients 12 02045 g004 550
Figure 4. Total fish intake and intake of fish high in n-3 LCPUFA (servings/month) by race/ethnicity. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between race/ethnicity groups in post hoc pairwise comparisons (p < 0.05).
Figure 4. Total fish intake and intake of fish high in n-3 LCPUFA (servings/month) by race/ethnicity. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between race/ethnicity groups in post hoc pairwise comparisons (p < 0.05).
Nutrients 12 02045 g004
Nutrients 12 02045 g005 550
Figure 5. Total fish intake and intake of fish high in n-3 LCPUFA (servings/month) by education level. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between education groups in post hoc pairwise comparisons (p < 0.05).
Figure 5. Total fish intake and intake of fish high in n-3 LCPUFA (servings/month) by education level. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate a significant difference between education groups in post hoc pairwise comparisons (p < 0.05).
Nutrients 12 02045 g005
Nutrients 12 02045 g006 550
Figure 6. Total fish intake and intake of fish high in n-3 LCPUFA (servings/month) by Federal Poverty Line (A) and Poverty Income Ratio (PIR) (B). Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). P-values represent within-group comparisons for total fish and fish high in n-3 LCPUFA.
Figure 6. Total fish intake and intake of fish high in n-3 LCPUFA (servings/month) by Federal Poverty Line (A) and Poverty Income Ratio (PIR) (B). Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). P-values represent within-group comparisons for total fish and fish high in n-3 LCPUFA.
Nutrients 12 02045 g006
Nutrients 12 02045 g007 550
Figure 7. EPA/DHA average daily intake (mg per 1000 kcal) categorized by diet only and diet + supplement use. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). p-values represent within group comparisons for EPA and DHA.
Figure 7. EPA/DHA average daily intake (mg per 1000 kcal) categorized by diet only and diet + supplement use. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). p-values represent within group comparisons for EPA and DHA.
Nutrients 12 02045 g007
Nutrients 12 02045 g008 550
Figure 8. EPA/DHA average daily intake (mg per 1000 kcal) categorized by supplement use. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate significant within-group differences in post hoc pairwise comparisons (p < 0.05).
Figure 8. EPA/DHA average daily intake (mg per 1000 kcal) categorized by supplement use. Data are presented as unadjusted means ± SE and were compared using the SURVEY package in R (version 3.4.2). Categories annotated with different letters indicate significant within-group differences in post hoc pairwise comparisons (p < 0.05).
Nutrients 12 02045 g008
Table
Table 1. Adequate Intakes for omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA).
Table 1. Adequate Intakes for omega-3 (n-3) long-chain polyunsaturated fatty acids (LCPUFA).
World Health Organization [14]AgeAI (Adequate Intake; per day)
DHA12–24 months10–12 mg/kg
EPA+DHA2–4 years100–150 mg
4–6 years150–200 mg
6–10 years200–250 mg
Adults200–250 mg
National Institutes of Health [18]AgeMale/Female (per day)
EPA+DHA1–3 years70 mg/70 mg
4–8 years90 mg/90 mg
9–13 years120 mg/100 mg
14–18 years160 mg/110 mg
19–50 years160 mg/110 mg
51 years160 mg/110 mg
mg = milligrams, kg = kilograms.
Table
Table 2. Descriptive statistics of the 2003–2014 National Health and Nutrition Examination Survey (NHANES) study population (n = 44,585).
Table 2. Descriptive statistics of the 2003–2014 National Health and Nutrition Examination Survey (NHANES) study population (n = 44,585).
CharacteristicsNMean (SE)
Age (years)44,58537.3 (22.1)
Calories (kcal)44,4822064 (793.6)
Poverty-Income Ratio41,6922.9 (1.7)
EPA intake (mg/1000 kcal)44,48216.3 (44.4)
DHA intake (mg/1000 kcal)44,48232.3 (68.6)
EPA+DHA intake (mg/1000 kcal)44,48248.5 (110.9)
Total fish intake (servings/30 days)29,0337.5 (6.4)
Fish high in n-3 LCPUFA intake (servings/30 days)24,9092.4 (3.4)
Fish low in n-3 LCPUFA intake (servings/30 days) 29,0335.4 (4.7)
CharacteristicsN%
GenderMale22,05649.0
Female22,52951.0
Race/EthnicityNon-Hispanic Black10,45312.0
Non-Hispanic White17,80966.7
Mexican-American92129.9
Other Hispanic 35885.0
Other35236.4
Education<high school and <19 years old12,44219.3
<high school637013.0
high school660119.5
>high school 13,64548.2
Income<median PIR26,60249.8
≥median PIR15,09050.2
<FPL10,77016.6
≥FPL30,92283.4
(PIR = Poverty-Income Ratio. Median PIR =2.73. FPL = Federal Poverty Line).
Table
Table 3. Proportion of participants taking a supplement containing EPA/DHA and probability of use by education, race/ethnicity, and income.
Table 3. Proportion of participants taking a supplement containing EPA/DHA and probability of use by education, race/ethnicity, and income.
Reported EPA/DHA Supplement Use (%)
Total Population2420
Education<high school and <19 y148 (1.5%)
<high school310 (5.5%)
High school458 (7.3%)
>high school1445 (11.3%)
Race/EthnicityNon-Hispanic Black330 (3.2%)
Non-Hispanic White1388 (9.0%)
Mexican American223 (3.0%)
Other Hispanic207 (5.4%)
Other272 (7.4%)
Income<median PIR990 (4.7%)
≥median PIR1262 (10.0%)
<FPL224 (2.6%)
≥FPL2028 (8.3%)

Share and Cite

MDPI and ACS Style

Cave, C.; Hein, N.; Smith, L.M.; Anderson-Berry, A.; Richter, C.K.; Bisselou, K.S.; Appiah, A.K.; Kris-Etherton, P.; Skulas-Ray, A.C.; Thompson, M.; et al. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003–2014. Nutrients 2020, 12, 2045. https://doi.org/10.3390/nu12072045

AMA Style

Cave C, Hein N, Smith LM, Anderson-Berry A, Richter CK, Bisselou KS, Appiah AK, Kris-Etherton P, Skulas-Ray AC, Thompson M, et al. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003–2014. Nutrients. 2020; 12(7):2045. https://doi.org/10.3390/nu12072045

Chicago/Turabian Style

Cave, Caleb, Nicholas Hein, Lynette M. Smith, Ann Anderson-Berry, Chesney K. Richter, Karl Stessy Bisselou, Adams Kusi Appiah, Penny Kris-Etherton, Ann C. Skulas-Ray, Maranda Thompson, and et al. 2020. "Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003–2014" Nutrients 12, no. 7: 2045. https://doi.org/10.3390/nu12072045

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop